Ameritas Advisory Services LLC Buys 2,262 Shares of Haleon plc (NYSE:HLN)

Ameritas Advisory Services LLC grew its stake in Haleon plc (NYSE:HLN) by 14.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 18,307 shares of the company’s stock after acquiring an additional 2,262 shares during the period. Ameritas Advisory Services LLC’s holdings in Haleon were worth $175,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Fortitude Family Office LLC bought a new position in Haleon in the 3rd quarter worth approximately $28,000. Versant Capital Management Inc raised its position in shares of Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after acquiring an additional 3,348 shares during the last quarter. Toronto Dominion Bank lifted its stake in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after acquiring an additional 3,470 shares during the period. Prospera Private Wealth LLC acquired a new stake in Haleon in the third quarter worth about $57,000. Finally, Brooklyn Investment Group raised its holdings in Haleon by 168.1% during the 4th quarter. Brooklyn Investment Group now owns 6,080 shares of the company’s stock worth $58,000 after purchasing an additional 3,812 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Trading Up 0.1 %

HLN opened at $9.40 on Friday. The firm’s fifty day moving average is $9.54 and its two-hundred day moving average is $9.72. The firm has a market cap of $42.53 billion, a PE ratio of 27.63, a price-to-earnings-growth ratio of 2.60 and a beta of 0.29. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.

Haleon (NYSE:HLN) last posted its earnings results on Thursday, October 31st. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.03. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.62 billion for the quarter, compared to analyst estimates of $3.74 billion. During the same period in the previous year, the company posted $0.10 earnings per share. Equities research analysts anticipate that Haleon plc will post 0.44 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a research report on Tuesday, October 1st. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. Finally, Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.